RANDOMIZED PHASE-III TRIAL OF CHEMO-IMMUNOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED STAGE-III, OPTIMAL DISEASE OVARIAN-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY

被引:12
作者
ALBERTS, DS
MASONLIDDIL, N
OTOOLE, RV
ABBOTT, TM
KRONMAL, R
HILGERS, RD
SURWIT, EA
EYRE, HJ
BAKER, LH
机构
[1] ARIZONA CANC CTR,TUCSON,AZ 85724
[2] OHIO STATE UNIV,CTR HLTH,COLUMBUS,OH 43210
[3] SW ONCOL GRP,CTR BIOSTAT,SEATTLE,WA 98104
[4] UNIV NEW MEXICO,ALBUQUERQUE,NM 87131
[5] WAYNE STATE UNIV,MED CTR,DETROIT,MI 48201
关键词
D O I
10.1016/0090-8258(89)90842-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:16 / 21
页数:6
相关论文
共 21 条
[1]  
ALBERTS DS, 1979, CANCER TREAT REP, V63, P325
[2]  
ALBERTS DS, 1985, SEMIN ONCOL, V12, P38
[3]  
ALBERTS DS, 1987, ADJUVANT THERAPY CAN, V5, P629
[4]  
ALBERTS DS, 1989, GYNECOL ONCOL, V32
[5]  
ALBERTS DS, 1982, IMMUNOTHERAPY HUMAN, P343
[6]  
BEREK JS, 1985, CANCER RES, V45, P4447
[7]   THERAPY OF STAGE-III (OPTIMAL) EPITHELIAL CARCINOMA OF THE OVARY WITH MELPHALAN OR MELPHALAN PLUS CORYNEBACTERIUM PARVUM - (A GYNECOLOGIC ONCOLOGY GROUP-STUDY) [J].
GALL, S ;
BUNDY, B ;
BEECHAM, J ;
WHITNEY, C ;
HOMESLEY, H ;
LIFSHITZ, S ;
ADCOCK, LL .
GYNECOLOGIC ONCOLOGY, 1986, 25 (01) :26-36
[8]  
GRECO FA, 1981, OBSTET GYNECOL, V58, P199
[9]  
GRIFFITHS CT, 1979, CANCER TREAT REP, V63, P235
[10]  
HACKER NF, 1983, OBSTET GYNECOL, V61, P413